BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26602278)

  • 1. Hit-to-lead optimization of phenylsulfonyl hydrazides for a potent suppressor of PGE2 production: Synthesis, biological activity, and molecular docking study.
    Kim M; Lee S; Park EB; Kim KJ; Lee HH; Shin JS; Fischer K; Koeberle A; Werz O; Lee KT; Lee JY
    Bioorg Med Chem Lett; 2016 Jan; 26(1):94-9. PubMed ID: 26602278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, structure determination, and biological evaluation of phenylsulfonyl hydrazide derivatives as potential anti-inflammatory agents.
    Park EB; Kim KJ; Jeong HR; Lee JK; Kim HJ; Lee HH; Lim JW; Shin JS; Koeberle A; Werz O; Lee KT; Lee JY
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5193-5197. PubMed ID: 27720548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel mPGES-1 inhibitors through screening of a chemical library.
    Park SJ; Han SG; Ahsan HM; Lee K; Lee JY; Shin JS; Lee KT; Kang NS; Yu YG
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7335-9. PubMed ID: 23147075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of N-amido-phenylsulfonamide derivatives as novel microsomal prostaglandin E
    Kim M; Kim G; Kang M; Ko D; Nam Y; Moon CS; Kang HM; Shin JS; Werz O; Lee KT; Lee JY
    Bioorg Med Chem Lett; 2021 Jun; 41():127992. PubMed ID: 33775835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel benzoxazole inhibitors of mPGES-1.
    Kablaoui N; Patel S; Shao J; Demian D; Hoffmaster K; Berlioz F; Vazquez ML; Moore WM; Nugent RA
    Bioorg Med Chem Lett; 2013 Feb; 23(3):907-11. PubMed ID: 23266122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E₂ synthase-1 enzyme (mPGES-1).
    Lauro G; Strocchia M; Terracciano S; Bruno I; Fischer K; Pergola C; Werz O; Riccio R; Bifulco G
    Eur J Med Chem; 2014 Jun; 80():407-15. PubMed ID: 24794772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of substituted benzoxazoles as inhibitors of mPGES-1: use of a conformation-based hypothesis to facilitate compound design.
    Walker DP; Arhancet GB; Lu HF; Heasley SE; Metz S; Kablaoui NM; Franco FM; Hanau CE; Scholten JA; Springer JR; Fobian YM; Carter JS; Xing L; Yang S; Shaffer AF; Jerome GM; Baratta MT; Moore WM; Vazquez ML
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1120-6. PubMed ID: 23298810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological characterization of benzenesulfonamides as dual species inhibitors of human and murine mPGES-1.
    Hanke T; Rörsch F; Thieme TM; Ferreiros N; Schneider G; Geisslinger G; Proschak E; Grösch S; Schubert-Zsilavecz M
    Bioorg Med Chem; 2013 Dec; 21(24):7874-83. PubMed ID: 24183739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragment-based discovery of novel and selective mPGES-1 inhibitors Part 1: identification of sulfonamido-1,2,3-triazole-4,5-dicarboxylic acid.
    Lee K; Pham VC; Choi MJ; Kim KJ; Lee KT; Han SG; Yu YG; Lee JY
    Bioorg Med Chem Lett; 2013 Jan; 23(1):75-80. PubMed ID: 23218602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation.
    Arhancet GB; Walker DP; Metz S; Fobian YM; Heasley SE; Carter JS; Springer JR; Jones DE; Hayes MJ; Shaffer AF; Jerome GM; Baratta MT; Zweifel B; Moore WM; Masferrer JL; Vazquez ML
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1114-9. PubMed ID: 23260349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of prostaglandin E(2) production by synthetic minor prenylated chalcones and flavonoids: synthesis, biological activity, crystal structure, and in silico evaluation.
    Rullah K; Mohd Aluwi MF; Yamin BM; Abdul Bahari MN; Wei LS; Ahmad S; Abas F; Ismail NH; Jantan I; Wai LK
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3826-34. PubMed ID: 25027933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of highly potent microsomal prostaglandin e2 synthase 1 inhibitors using the active conformation structural model and virtual screen.
    He S; Li C; Liu Y; Lai L
    J Med Chem; 2013 Apr; 56(8):3296-309. PubMed ID: 23527738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new γ-hydroxybutenolides that preferentially inhibit the activity of mPGES-1.
    De Simone R; Bruno I; Riccio R; Stadler K; Bauer J; Schaible AM; Laufer S; Werz O
    Bioorg Med Chem; 2012 Aug; 20(16):5012-6. PubMed ID: 22795900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and PGE₂ production inhibition of s-triazine derivatives as a novel scaffold in RAW 264.7 macrophage cells.
    Kang SM; Lee J; Jin JH; Kim M; Lee S; Lee HH; Shin JS; Lee KT; Lee JY
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5418-22. PubMed ID: 25453800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of 2-aryl substituted quinazolin-4(3H)-one, pyrido[4,3-d]pyrimidin-4(3H)-one and pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as microsomal prostaglandin E(2) synthase-1 inhibitors.
    Banerjee A; Pawar MY; Patil S; Yadav PS; Kadam PA; Kattige VG; Deshpande DS; Pednekar PV; Pisat MK; Gharat LA
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4838-44. PubMed ID: 25260492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular docking and competitive binding study discovered different binding modes of microsomal prostaglandin E synthase-1 inhibitors.
    He S; Lai L
    J Chem Inf Model; 2011 Dec; 51(12):3254-61. PubMed ID: 22077876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template.
    Wang J; Limburg D; Carter J; Mbalaviele G; Gierse J; Vazquez M
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1604-9. PubMed ID: 20144869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production.
    Ikeda-Matsuo Y; Ikegaya Y; Matsuki N; Uematsu S; Akira S; Sasaki Y
    J Neurochem; 2005 Sep; 94(6):1546-58. PubMed ID: 16000148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
    Koeberle A; Werz O
    Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886.
    Riendeau D; Aspiotis R; Ethier D; Gareau Y; Grimm EL; Guay J; Guiral S; Juteau H; Mancini JA; Méthot N; Rubin J; Friesen RW
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3352-5. PubMed ID: 15953724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.